Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care

Publisher： Karger

E-ISSN： 1662-8063|18|6|349-358

ISSN： 1662-4246

Source： Public Health Genomics, Vol.18, Iss.6, 2015-0, pp. : 349-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 137-143

Karger

Access to resources Recommend Favorite

Getting Personal: Accelerating Personalised and Precision Medicine Integration into Clinical Cancer Research and Care in Clinical Trials

By  

Public Health Genomics, Vol. 18, Iss. 6, 2015-0 ,pp. : 325-328

Karger

Access to resources Recommend Favorite

A Health Services Research Agenda for Cellular, Molecular and Genomic Technologies in Cancer Care

By  

Public Health Genomics, Vol. 12, Iss. 4, 2009-02 ,pp. : 233-244

Karger

Access to resources Recommend Favorite

Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?

By  

Public Health Genomics, Vol. 18, Iss. 6, 2015-0 ,pp. : 329-337

Karger

Access to resources Recommend Favorite

Evolving `omics' technologies for diagnostics of head and neck cancer

By Nagaraj Nagathihalli S.  

Briefings in Functional Genomics and Proteomics, Vol. 8, Iss. 1, 2009-01 ,pp. : 49-59

Oxford University Press

Access to resources Recommend Favorite